Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Xbiotech Inc (XBIT)

16.37   -0.25 (-1.5%) 01-20 23:54
Open: 16.79 Pre. Close: 16.62
High: 17.11 Low: 16.27
Volume: 63,124 Market Cap: 479M
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases. Its product candidates include 514G3, an anti-infective antibody that is in Phase II clinical trial for the treatment of Staphylococcus Aureus infections; and other anti-infectious disease antibodies, which are in pre-clinical development to treat Clostridium Difficile, influenza, Ebola, and Herpes Varicella Zoster (Chickenpox). XBiotech Inc. has a collaboration with BioBridge Global for the development of potential COVID 19 treatment based on natural antibodies from recovered patients. The company was founded in 2005 and is headquartered in Austin, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.15 - 17.234 17.234 - 17.303
Low: 16.042 - 16.154 16.154 - 16.245
Close: 16.214 - 16.383 16.383 - 16.519

Technical analysis

as of: 2021-01-20 4:53:57 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 20.65     One year: 22.59
Support: Support1: 15.00    Support2: 12.48
Resistance: Resistance1: 17.68    Resistance2: 19.34
Pivot: 16.51
Moving Average: MA(5): 16.62     MA(20): 16.55
MA(100): 18.42     MA(250): 16.26
MACD: MACD(12,26): -0.32     Signal(9): -0.38
Stochastic oscillator: %K(14,3): 49.49     %D(3): 54.38
RSI: RSI(14): 42.79
52-week: High: 23.87  Low: 8.72  Change(%): -28.2
Average Vol(K): 3-Month: 8946  10-Days: 8184

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
XBIT has closed above bottom band by 44.3%. Bollinger Bands are 13.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 19 Jan 2021
XBiotech Inc. (XBIT) Soars 1.59% on January 19 - Equities.com

Tue, 19 Jan 2021
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy - GlobeNewswire

Mon, 11 Jan 2021
XBiotech Inc. (XBIT) Soars 1.54% on January 11 - Equities.com

Sat, 09 Jan 2021
XBiotech (NASDAQ:XBIT) Raised to "Hold" at BidaskClub - MarketBeat

Fri, 08 Jan 2021
XBiotech Inc. (XBIT) Soars 4.67% on January 08 - Equities.com

Mon, 04 Jan 2021
XBiotech Inc. (XBIT) Soars 3.32% on January 04 - Equities.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 29
Shares Float (M) 18
% Held by Insiders 39.40
% Held by Institutions 14.40
Shares Short (K) 1,700
Shares Short P. Month (K) 1,690

Stock Financials

EPS 16.450
EPS Est This Year -1.290
EPS Est Next Year -1.540
Book Value (p.s.) 11.840
Profit Margin 1748.38
Operating Margin -68.85
Return on Assets (ttm) -7.9
Return on Equity (ttm) 329.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share 1.324
EBITDA (p.s.) -0.836
Qtrly Earnings Growth
Operating Cash Flow (M) -69
Levered Free Cash Flow (M) -13

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value 1.38
Price to Sales 12.37
Price to Cash Flow -6.99

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.